Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by trauma patients in the intensive care unit

The Journal of Hospital Infection
Caroline MarshallDenis Spelman

Abstract

In a previous study in the intensive care unit (ICU) of the Alfred Hospital, Melbourne, Australia, it was demonstrated that trauma patients were at particular risk of becoming colonized by methicillin-resistant Staphylococcus aureus (MRSA). We examined risk factors for MRSA acquisition in these patients using a cohort study comparing the 31 patients who acquired MRSA with 65 who did not. Data collected included ICU length of stay (LOS), mechanism of trauma, site of injury, type of surgery, trauma severity and antibiotic usage. Odds ratios (OR) were determined and adjusted for LOS. LOS in the ICU was a significant univariate predictor of MRSA acquisition (OR 13.7). When adjusted for LOS, mechanism of trauma (OR 10.4), laparotomy (OR 6.3) and administration of ticarcillin/clavulanic acid (OR 4.5) or glycopeptides (OR 5.9) remained significant. We confirmed our previous finding that LOS was associated with MRSA acquisition. Receipt of antibiotics correlated with reported literature. Novel associations were road trauma as a mechanism and laparotomy.

References

Jul 1, 1981·The Journal of Infectious Diseases·F Espersen, J Gabrielsen
Jan 1, 1996·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·A AsensioM Martinez-Ferrer
Jun 12, 1998·The Australian and New Zealand Journal of Surgery·M McDonaldA Forbes
Feb 2, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M OnoratoC G Mayhall
Mar 19, 1999·Emerging Infectious Diseases·R J RubinA Moiduddin
Apr 16, 1999·American Journal of Surgery·A BozorgzadehH Noorollah
Aug 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D LandmanJ M Quale
Mar 10, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·T KimA E Simor
Mar 15, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Mar 23, 2002·The American Journal of the Medical Sciences·Nilton A RezendeJohn E McGowan
May 11, 2002·Archives of Surgery·George C VelmahosDemetrios Demetriades
Jun 1, 2002·The Journal of Antimicrobial Chemotherapy·Eileen M Graffunder, Richard A Venezia
Jun 6, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Caroline MarshallDenis Spelman

❮ Previous
Next ❯

Citations

May 9, 2006·Critical Care Clinics·Douglas N Fish, Martin J Ohlinger
Jul 4, 2007·Transplant Infectious Disease : an Official Journal of the Transplantation Society·M HashimotoM Makuuchi
Aug 3, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G De AngelisS Harbarth
Mar 25, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A MurthyS Harbarth
Jan 13, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Alexander L A BloemendaalJan Verhoef
Sep 10, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·David M TehraniSusan S Huang
Sep 13, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Stephan HarbarthDidier Pittet
May 24, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jon P FurunoEli N Perencevich
Aug 6, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·A L A BloemendaalJ Verhoef
Mar 14, 2018·Antimicrobial Agents and Chemotherapy·Megan K LutherKerry L LaPlante
Mar 1, 2005·Journal of the Royal Army Medical Corps·M J Brookes, P Richards
May 25, 2006·The Journal of Bone and Joint Surgery. British Volume·S J RocheJ P McCabe
Oct 7, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jo-anne M SalangsangCarlene A Muto
May 8, 2013·Mycoses·John SimonGeorge Dimopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Caroline MarshallDenis Spelman
American Journal of Respiratory and Critical Care Medicine
J L TrouilletC Gibert
© 2022 Meta ULC. All rights reserved